Source study found
Story checked
Type 2 diabetes breakthrough as 54% achieve remission in just 6 months | ScienceDaily (opens in a new tab)
sciencedaily.com · 2026-10-30
Short answer
Not assessedCheck incomplete.
We found a likely source study, but its evidence could not be prepared for claim review. The article's claims remain unverified.
Share this check
The story
Type 2 diabetes breakthrough as 54% achieve remission in just 6 months | ScienceDaily
sciencedaily.com · 2026-10-30
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Source study identified.
A source study was identified, but the study's evidence could not be prepared for claim assessment. No claim verdicts are available.
View article claimsThe source study
Low energy diet plus supervised exercise vs. usual care alone in people with early-onset type 2 diabetes (RESET for Remission): a randomised, open-label, blinded-endpoint efficacy trial
Evidence layer
Claim by claim
A source study was identified, but the study's evidence could not be prepared for claim assessment. The claims below have not been assessed.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 6Not checkedA carefully structured combination of diet and exercise may offer a powerful way to put type 2 diabetes into remission in younger adults.View evidenceHide evidence
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Claim 2 of 6Not checkedIn a new clinical trial, more than half of participants who followed an intensive lifestyle program achieved remission within just six months, compared with only 4% of those receiving standard care.View evidenceHide evidence
As statedmore than half vs 4%; six months
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Claim 3 of 6Not checkedThe findings were presented at the Annual Meeting of the European Association for the Study of Diabetes and published in The Lancet Regional Health Americas.View evidenceHide evidence
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Claim 4 of 6Not checkedThe trial enrolled adults aged 18 to 45 with early-onset type 2 diabetes and obesity who were not using insulin, and compared an intensive low-calorie diet plus supervised exercise with usual care.View evidenceHide evidence
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Claim 5 of 6Not checkedThe article says the intervention group lost substantially more weight and fat, and that no severe adverse events were reported, although minor side effects were more common during the intensive diet phase.View evidenceHide evidence
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Claim 6 of 6Not checkedThe researchers say the program may help preserve muscle mass during rapid weight loss and could be especially relevant for people planning pregnancy, but longer-term studies are needed.View evidenceHide evidence
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Method layer
NewsLink found the paper. Tessa takes you deeper.
NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.
Open the paper in Tessa
Low energy diet plus supervised exercise vs. usual care alone in people with early-onset type 2 diabetes (RESET for Remission): a randomised, open-label, blinded-endpoint efficacy trial
The Lancet Regional Health - Americas · 2026
Why this one
Near certain
NewsLink found the paper. Tessa is where you inspect it deeply.
Papers considered
The selected paper, plus nearby candidates.
Crossref, Europe PMC, PubMed · 41 candidate papers
Low energy diet plus supervised exercise vs. usual care alone in people with early-onset type 2 diabetes (RESET for Remission): a randomised, open-label, blinded-endpoint efficacy trial
The Lancet Regional Health - Americas · 2026 · Crossref
Measles, mistrust, and missed protection in the Americas
The Lancet Regional Health - Americas · 2026 · Crossref
Phylodynamic analysis reveals asymmetric and accelerating global spread of dengue virus
2026 · Europe PMC
Medical AI in the Americas: policy, validation, and representativeness
The Lancet Regional Health - Americas · 2026 · Crossref
Food systems performance evaluated against targets and benchmarks reveals urgent gaps and a path to 2050.
2026 · Europe PMC
When recommendations meet reality: the challenge of walking in the Americas
The Lancet Regional Health - Americas · 2026 · Crossref
And 35 more candidates considered.